Tandem Diabetes Care (NASDAQ:TNDM) reported record fourth-quarter and full-year 2025 results while outlining a major shift in ...
Tandem Diabetes Care, Inc. delivered strong Q4 '25 results, with revenue and gross margin beats driving a 32% stock surge.
Tandem Diabetes Care TNDM shares are surging on Friday following the company’s recent financial results and guidance for 2026. The stock is moving higher as the broader market is experiencing positive ...
Brown Capital Management, an investment management company, released its fourth quarter 2025 investor letter for “The Brown Capital Management Small Company Fund”. A copy of the letter can be ...
Investing.com -- Tandem Diabetes Care Inc (NASDAQ:TNDM) shares fell 5% in after-hours trading Monday after the company announced plans to offer $200 million in convertible senior notes due 2032 in a ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Tandem, a pet healthcare startup on a mission to deliver unrivaled, affordable healthcare to every pet, has secured $10 million in pre-seed funding to redefine ...
Received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for extended wear use of the SteadiSet Infusion Set Filed a 510(k) with the FDA for Android mobile control of the Tandem Mobi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results